Patrik Jeanmonod - 24 Aug 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Financial Officer
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Patrik Jeanmonod
Issuer symbol
CTKB
Transactions as of
24 Aug 2022
Net transactions value
-$47,075
Form type
4
Filing time
25 Aug 2022, 18:14:04 UTC
Previous filing
19 Aug 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Sale $47,075 -3,500 -3.6% $13.45 92,563 24 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.